(1)
Comprehensive Analysis of a NAD+ Metabolism-Derived Gene Signature to Predict the Prognosis and Immune Landscape in Endometrial Cancer. Biomol Biomed 2024, 24 (2), 346–359. https://doi.org/10.17305/bb.2023.9489.